Kestra Medical Technologies, Ltd. (KMTS) — Financial statements
Income statement, balance sheet, and cash flow for Kestra Medical Technologies, Ltd. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 60↑115.1% | 28↑264.5% | 8 | 0.00 | 0.00 | |
| Cost of Revenue | 36↑29.7% | 27↑50.2% | 18 | 0.00 | 0.00 | |
| Gross Profit | 24↑6587.8% | 0.36↑103.4% | -11 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 16↑1.0% | 15↓1.7% | 16↓16.2% | 19↓17.5% | 23 | |
| General & Administrative Expenses | 0.00↓100.0% | 29↑53.2% | 19 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 41↑16.5% | 35↑151.2% | 14↑113.3% | 7 | |
| SG&A Expenses | 115↑64.3% | 70↑29.5% | 54↑288.5% | 14↑113.3% | 7 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 131↑52.9% | 85↑22.4% | 70↑113.3% | 33↑11.6% | 29 | |
| Total Costs & Expenses | 166↑47.2% | 113↑28.2% | 88↑169.2% | 33↑11.6% | 29 | |
| Operating Results | ||||||
| Operating Income | -106↓25.1% | -85↓5.8% | -80↓145.9% | -33↓11.6% | -29 | |
| Depreciation & Amortization | 8↓31.1% | 12↑138.1% | 5↑1056.0% | 0.42↓12.1% | 0.48 | |
| EBITDA | -98↓28.4% | -76↓3.5% | -74↓128.1% | -32↓12.1% | -29 | |
| EBIT | -106↓20.6% | -88↓11.8% | -79↓140.0% | -33↓11.7% | -29 | |
| Interest & Other Income | ||||||
| Net Interest Income | -5↑27.2% | -6↓10.7% | -6↓381.9% | -1 | 0.00 | |
| Interest Income | 3 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 8↑24.1% | 6↑10.7% | 6↑381.9% | 1 | 0.00 | |
| Non-Operating Income | -0.43↓115.4% | 3↑253.4% | -2↓4907.9% | 0.04 | 0.00 | |
| Other Income / Expenses | -7↑19.2% | -9↓137.6% | -4↓215.3% | -1 | 0.00 | |
| Income Before Tax | -114↓20.8% | -94↓11.7% | -84↓148.3% | -34↓15.7% | -29 | |
| Income Tax Expense | 0.14↑462.5% | 0.02↑60.0% | 0.02↓92.0% | 0.19↑26.4% | 0.15 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -114↓20.9% | -94↓11.7% | -84↓147.0% | -34↓15.7% | -29 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -114↓20.9% | -94↓11.7% | -84↓147.0% | -34↓15.7% | -29 | |
| Bottom-Line Net Income | -126↓25.1% | -101↓16.3% | -87↓154.4% | -34↓15.7% | -29 | |
| EPS (Basic) | -5.13↓151.5% | -2.04↓16.6% | -1.75↓153.6% | -0.69↓16.9% | -0.59 | |
| EPS (Diluted) | -5.13↓151.5% | -2.04↓16.6% | -1.75↓153.6% | -0.69↓16.9% | -0.59 | |
| Weighted Average Shares | 50↑0.0% | 50↑0.0% | 50↑0.0% | 50↑0.0% | 50 | |
| Weighted Average Diluted Shares | 50↑0.0% | 50↑0.0% | 50↑0.0% | 50↑0.0% | 50 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.